Portfolio company
Cime Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops an automated drug discovery platform using synthetic chemistry and artificial intelligence to create therapeutic molecules for pharmaceutical organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
Deepcure
This company develops small molecule therapies for pharmaceutical organisations to treat inflammatory and autoimmune diseases using artificial intelligence and automated discovery tools.
Chemify
This company provides automated molecular design and synthesis services to pharmaceutical, biotechnology and industrial partners using robotics and artificial intelligence.
DeepMirror
This company develops an artificial intelligence platform for medicinal chemists at biotechnology and pharmaceutical firms to design and optimise drug molecules.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
Terray
This company develops a generative artificial intelligence and high-throughput experimentation platform for pharmaceutical and biotechnology organisations to accelerate small molecule drug discovery.
Avicenna Biosciences
The company develops a machine learning platform to optimise small molecule drug discovery and lead-to-candidate processes for biotechnology and pharmaceutical organisations.
Biorelate
This company develops an artificial intelligence platform that curates biomedical data to support drug discovery for pharmaceutical and life sciences organisations.
